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Ours is a scientific era captivated by
molecular reductionism. We often suc-
cumb to a belief that the key to under-
standing complex organisms resides in
discovering the molecules and molec-
ular properties that undergird macro-
scopic phenomena. Once the relevant
molecular secrets are unlocked, the im-
plications of their properties for macro-
scopic behavior is believed to be obvi-
ous and direct, at least in-the-large. The
track record for this philosophical
viewpoint can be quite convincing. Mu-
tations in cone visual pigments explain
differences in color perception (Merbs
and Nathans, 1992). Long-term poten-
tiation at synapses explains spatial
learning (Silva et al., 1992a, 1992b). A
chloride channel defect gives rise to
cystic fibrosis (Rommens et al., 1989).
This issue's paper by Cannon and Co-
rey concerns the inherited disease of
hyperkalemic periodic paralysis (HPP
(Gamstorp, 1956)), one of the most
beautiful examples of pathophysiolog-
ical disorders explainable by the molec-
ular reductionist approach. Patients
with this affliction suffer attacks of
muscular rigidity or flaccidity follow-
ing modest elevations of serum [K+].
The molecular culprit appears to be a
mutant voltage-gated sodium channel
in skeletal muscle, which fails to inac-
tivate with maintained depolarization.
Yet, there has been a worrisome gap be-
tween the marked sequelae of the dis-
ease and the admittedly small defect
found in sodium channel function.
Could there be more to the story? Can-
non and Corey do not add here to the
molecular details of the picture; rather,
their contribution is to elaborate math-
ematically the consequences of a very
slight defect in sodium channel inacti-
vation upon skeletal muscle excitabil-
ity. Their analysis shows that very mod-
est perturbations in sodium channel
ing disturbances in skeletal muscle
function. Beyond clarifying the molec-
ular pathogenesis of HPP, Cannon and
Corey's paper serves as an elegant re-
minder of the limitations of molecular
reductionism, and the crucial need for
other scientific approaches. To appreci-
ate the full impact of their work, it is
worth summarizing the quickening
pace of research on HPP.
Physiological studies of muscle de-
rived from HPP patients began to im-
plicate faulty sodium channels as the
root cause of the disease. In the mid
1980s, Lehmann-Horn and others pro-
vided preliminary evidence that an in-
crease in extracellular [K] produced ex-
cess depolarization in muscle fibers
biopsied from HPP patients. Coarse
voltage clamp measurements showed
that modest depolarization activated a
small, noninactivating inward current
that was blockable by tetrodotoxin.
They surmized that sodium channels
defective in inactivation could be the
cause of HPP. Cannon et al. (1991) pro-
vided the single-channel evidence that
something was indeed awry with sodi-
um channels of myotubes cultured from
HPP patients. Not only did a significant
fraction of sodium channels fail to in-
activate, but the unusual lack of inac-
tivation was observed only when extra-
cellular [K] was raised. This provided a
most satisfying molecular explanation
for the K+ dependence of HPP attacks.
Work from several laboratories used
genetic approaches to show tight link-
age ofHPP inheritance to the adult skel-
etal muscle sodium channel gene on
chromosome 17. Two specific muta-
tions were later found in the coding re-
gion of the skeletal muscle sodium
channel, and both were very unlikely to
represent benign polymorphisms. Fi-
nally, the sodium channel mutations
identified in HPP patients were intro-
duced into wild-type sodium channels,
expressed in mammalian cells. These
channels failed to inactivate to the ex-
tent observed in wild-type channels
(Cannon and Strittmatter, 1993), there-
by building an apparently air-tight case
for the causative role of mutant sodium
channels in HPP.
Nevertheless, there remained some
ure of sodium channels to inactivate oc-
curred in only a few percent of the so-
dium channels (Cannon et al., 1991). It
seemed a leap of faith to expect that this
miniscule alteration in sodium channel
gating could produce the broad panora-
ma of conspicuous electrophysiologi-
cal disturbances in HPP. Moreover,
when the HPP mutations were intro-
duced into wild-type sodium channels
(Cannon and Strittmatter, 1993), the
slight failure to inactivate was not sen-
sitive to external [K], as were the sodi-
um channels in myotubes cultured from
HPP patients. How, then, could the po-
tassium dependence of HPP attacks be
explained? Were the sodium channels
in cultured myotubes not representative
of sodium channels in vivo? Could the
sodium channel gating defects repre-
sent only minute epiphenomena of a
more fundamental molecular defect?
Two approaches were used to ad-
dress these concerns: one physiologi-
cal, and the other theoretical. The phys-
iological approach (Cannon and Corey,
1993) aimed to create an HPP model by
using a pharmacological agent to slow
inactivation in a small fraction of sodi-
um channels in normal skeletal muscle
fibers. This is rather like a quick-and-
dirty version of a transgenic animal
model for HPP. The empirical result is
that HPP-like behavior is created, in-
cluding the potassium dependence of
"attacks." Thus, inactivation need fail
in only a small action of sodium chan-
nels to create the disease, and the po-
tassium sensitivity of HPP can arise as
an emergent system property of the
muscle. While this empirical approach
demonstrates the sufficiency of modest
sodium channel gating defects in pro-
ducing HPP, it doesn't tell us how this
comes about. That's where this issue's
theoretical analysis by Cannon and Co-
rey makes an enormous contribution.
The first half of their paper describes
numerical integration of a system of
nonlinear Hodgkin-Huxley-type equa-
tions that describe skeletal muscle ex-
citability. The surface membrane and
t-tubule compartments are treated as
distinct entities, and the essential spirit
of the analysis is not much different
than the model of Adrian and Marshall
ill-fitting pieces to the puzzle. The fail-
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gating lead quite naturally to'devastat- (1976). The distinction of the Cannon
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and Corey model is that the analysis
aims specifically to evaluate the ability
of a small defect in sodium channel in-
activation to produce HPP-like behav-
ior, and it does so completely. However,
the numerical analysis is no more than
a theoretical version of the physiolog-
ical validation described above; the
system of nonlinear differential equa-
tions are sufficiently complex that we
still don't understand how HPP behav-
ior arises from such a minor defect in
sodium channel gating. The major ad-
vance comes in the second half of the
paper. Here Cannon and Corey reduce
the full-scale model into a two-variable
approximation, amenable to classical
phase-plane analysis. Although this sort
of reduction of Hodgkin-Huxley mod-
els is not new (FitzHugh, 1961, 1969;
Nagumuo et al., 1962;), never has the
approach been more elegantly and aptly
applied to a critically important prob-
lem. The phase-plane analysis repre-
sents the entire repertoire of behaviors
of which the system is capable, all in
terms of a two-dimensional graph. The
impact of elevated [K] and sluggish so-
dium channel inactivation become ap-
parent through "a rapid geometric intu-
ition." Hence, the reduced-model
analysis allows us to know why just a
few bad sodium channels and elevated
external [K] can conspire to create my-
otonia or paralysis.
This initial chapter in HPP research
opens up exciting possibilities for the
future. Certainly other specific sodium
channel mutations will be found in dif-
ferent patients diagnosed under the
broad umbrella of HPP. Elaborating the
functional consequences of these will
contribute to our understanding of
structure-function relationships in sodi-
um channels, as well as to explain, per-
haps, the discrepant findings regarding
the potassium sensitivity of sodium
channels (Cannon et al. (1991) versus
Cannon and Strittmatter (1993)). Dif-
ferent mutational variants may have
been involved. The pace of discovery of
defective channels in related inherited
disorders is likely to quicken, and quan-
titative analysis of the functional con-
sequences of these will be required.
Ultimately, gene therapy involving
knockout and/or replacement of misbe-
having components will follow.
Of more general import, the reduced
model of Cannon and Corey points to
a type of analysis that will become
increasingly important. It is certainly
essential to identify the aberrant mole-
cules involved in disease. But mole-
cules interact with each other in gigan-
tic dynamical systems to produce
physiological function. So the trans-
duction from molecular properties to
organismic function cannot always be
obvious and direct, but is more often
subtle and complex. Huge numerical
integrations will help in linking up
these two domains, just as brute-force
molecular dynamic simulations help
elucidate structure-function relations of
proteins. However, what is critically
required beyond these computer-
intensive approaches is this: an under-
standing of how certain molecular
properties translate into unexpected
macroscopic behavior. The Cannon and
Corey strategy succeeds royally in the
particular setting of HPP, but there will
no doubt be instances where problems
can't be boiled down into two state vari-
ables, and alternate analytical strategies
and approaches will need to be devel-
oped and applied. Answering this need
constitutes an ongoing challenge for
biophysics.
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